Go to deals
Private Equity | Saúde

Gilde Healthcare has invested in Tandarts Today

Gilde Healthcare has invested in Tandarts Today, a fast-growing dental chain in the Netherlands. The investment will allow Tandarts Today to accelerate its buy-and-build strategy and become a leading dental chain in the Netherlands. Financial details have not been disclosed.

Tandarts Today, founded in 2015, offers all disciplines of regular dentistry, including special treatments such as implantology, orthodontics, periodontology and aesthetic treatments. Furthermore, through its own dental laboratories, it develops hockey bits, custom-made prostheses, bridges and other dental work pieces.

Gilde Healthcare is a specialized European healthcare investor managing over US$1.5 billion across two fund strategies: venture & growth capital and private equity. Gilde Healthcare’s venture & growth capital fund invests in health tech and therapeutics. The venture & growth companies are based in Europe and North America. Gilde Healthcare’s private equity fund invests in profitable European lower mid-market healthcare companies, with a focus on the Benelux and DACH regions. The private equity fund targets healthcare, suppliers of medical products and service providers in the healthcare market.

Oaklins’ team in the Netherlands acted as the exclusive financial advisor to the seller in this transaction.

Entidades
“I am delighted to welcome Gilde Healthcare as a shareholder in Tandarts Today. Their experience in buy-and-build strategies combined with their healthcare angle and focus makes Gilde Healthcare the perfect partner to realize Tandarts Today’s growth objectives. Oaklins played a fundamental role in identifying Gilde Healthcare as a buyer and realizing the transaction in a dedicated and professional manner.”

Ruben Hoefnagels

Founder and CEO, Tandarts Today

Falar com a equipa da transação

Adse de Kock

Partner
Amesterdão, Países Baixos
Oaklins Netherlands

Sander van 't Spijker

Associate Director
Amesterdão, Países Baixos
Oaklins Netherlands

Transações relacionadas

UKAT Group has acquired Bayberry Limited
Private Equity | Saúde

UKAT Group has acquired Bayberry Limited

UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.

Saber mais
Medicija has acquired Saulės Šeimos Medicinos Centras
Saúde

Medicija has acquired Saulės Šeimos Medicinos Centras

Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.

Saber mais
Quimpharma has completed the divestiture of a product portfolio to Megalabs
Saúde

Quimpharma has completed the divestiture of a product portfolio to Megalabs

Quimpharma has completed the divestiture of a product portfolio to Megalabs México.

Saber mais